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Escherichia coli O157:H7 causes life-threatening outbreaks of diarrhea, hemorrhagic colitis, and hemolytic-
uremic syndrome in humans and significant economic loss in agriculture and could be a potential agent of
bioterrorism. Although the prevalence of E. coli O157:H7 in cattle and other species with which humans have
frequent contact is high, human infections are relatively uncommon, despite a low infectious dose. A plausible
explanation for the low disease incidence is the possibility that not all strains are virulent in humans. If there
are substantial differences in virulence among strains in nature, then human disease may select for high
virulence. We used a gnotobiotic piglet model to investigate the virulence of isolates from healthy cattle and
from humans in disease outbreaks and to determine the correlation between production of Shiga toxin 1 (Stx1)
and Stx2 and virulence. Overall, E. coli O157:H7 strains isolated from healthy cattle were less virulent in
gnotobiotic piglets than strains isolated from humans during disease outbreaks. The amount of Stx2 produced
by E. coli O157:H7 strains correlated with strain virulence as measured by a reduction in piglet survival and
signs of central nervous system disease due to brain infarction. The amount of Stx1 produced in culture was
not correlated with the length of time of piglet survival or with signs of central nervous system disease. We
suggest that disease outbreaks select for producers of high levels of Stx2 among E. coli O157:H7 strains shed
by animals and further suggest that Stx1 expression is unlikely to be significant in human outbreaks.
Escherichia coli O157:H7 causes both outbreaks and spo-
radic cases of diarrhea, hemorrhagic colitis, and hemolytic-
uremic syndrome (HUS). E. coli O157:H7 isolates produce
several factors that are believed to contribute to virulence,
including Shiga toxin 1 (Stx1), Stx2, and several proteins en-
coded in the locus of enterocyte effacement pathogenicity is-
land (18, 31, 44). Stxs are A-B-type toxins that inhibit protein
synthesis in affected cells, particularly endothelial cells in small
blood vessels (8, 9, 37, 38). Following bacterial colonization of
the intestine, the toxins are thought to enter the systemic
circulation by crossing the intestinal mucosa and to be carried
systemically on the surfaces of polymorphonuclear leukocytes
(1, 2, 61). Stxs are then transferred to endothelial cells and
cause damage with fibrin deposition in and thrombosis of
arterioles and other small- to medium-sized blood vessels in
certain target organs, including the kidney, colon, and brain,
which result in infarcts in these organs (14, 43, 44, 51, 60, 66).
Based on studies in various animal models, Stxs also appear
to be capable of causing direct damage to tissues other than the
endothelium, including the villous epithelium in the small in-
testine (26), the renal tubular epithelium (42, 67), neurons
(19), and myelinated nerves in the central nervous system
(CNS) (21). Most patients fully recover from bloody diarrhea,
but some develop life-threatening diseases of the kidneys and
CNS; approximately 15% of the cases in children result in
HUS (60). With early implementation of aggressive supportive
therapy, including dialysis, the risk of death due to renal failure
has been reduced substantially. However, about one-third of
HUS cases involve significant encephalopathy, and brain injury
is the leading cause of death associated with acute HUS
(47, 54).
E. coli O157:H7 infections are typically contracted through
consumption of contaminated food or contact with contami-
nated water, animal feces, or infected animals. Several disease
outbreaks have been associated with contaminated beef, sug-
gesting that cattle are an important reservoir for human infec-
tion (5, 15). However, despite the high prevalence of E. coli
O157:H7 in cattle herds (16, 29, 55) and the low infectious
dose in humans (57, 63, 64), the incidence in humans is quite
low.
The discrepancy between the present and historic incidence
in humans and the prevalence of E. coli O157:H7 in cattle
today and in beef products in the past suggest that there is
significant variability among the typical strains harbored by
animals and the strains isolated from severe human infections.
Kim et al. reported that E. coli O157:H7 strains isolated from
diseased humans were members of a different lineage than
strains typically isolated from healthy cattle (27). Gally et al.
compared 30 E. coli serotype O157 strains from human disease
cases in Scotland to a similar number of strains isolated from
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asymptomatic Scottish cattle for production of hemolysin,
EspP, Tir, and EspD (32, 33, 49, 50). While few genotypic
differences were observed among the strains from the two
sources, strains isolated from infected humans produced sig-
nificantly more EspD and Tir than strains isolated from cattle.
Ritchie et al. compared E. coli O157:H7 strains isolated from
sporadic cases of HUS with isolates obtained from cattle pas-
tures and found that both basal and mitomycin C-induced Stx2
production by HUS-associated E. coli O157:H7 was signifi-
cantly greater than production by bovine isolates (46).
We have reported that oral challenge of 1-day-old gnotobi-
otic pigs with E. coli O157:H7 strains expressing both Stx1 and
Stx2 or only Stx2 and not Stx1 results in signs of CNS disease,
vascular lesions, hemorrhage, and infarcts in the brain (18).
Other workers reported similar observations (13, 65). Admin-
istration of anti-Stx2 serum protects gnotobiotic piglets inocu-
lated with Stx2 E. coli O157:H7 against the development of
brain vascular lesions, associated brain infarcts, and CNS clin-
ical signs, providing evidence that the lesions are directly or at
least indirectly caused by Stx2 (10, 12).
More recent studies have further shown that myelin degen-
eration occurs in the brain and that glomerular, arteriolar, and
tubular lesions occur in the kidneys of gnotobiotic piglets in-
oculated with Stx2 E. coli O157:H7 (21, 42). In the kidneys,
thrombotic microangiopathy (TMA), which is the morpholog-
ical hallmark of HUS in humans, was consistently seen, and
small preglomerular arterioles were demonstrated to express
Gb3/CD77 (21, 42). Larger arteries and glomerular capillary
endothelial cells were not found to express Gb3/CD77 (21). In
these two studies, despite developing renal lesions, the piglets
did not develop clinical signs of HUS (21, 42). In the one study
in which they were investigated, clinical pathology laboratory
parameters of HUS (uremia, hemolytic anemia, and thrombo-
cytopenia) also were not detected (21); however, all of the
piglets developed signs of CNS dysfunction, and five of six
animals developed cerebellar microhemorrhages, lesions
which were attributable to Stx-induced damage (21). In addi-
tion, the arachnoidea and endothelial cells of small arteries in
the CNS expressed Gb3/CD77 (21). In the study of Pohlenz et
al. (42), a retrospective histological examination of formalin-
fixed kidneys from gnotobiotic piglets inoculated with different
serotypes of Stx-producing E. coli was conducted. In addition
to finding TMA and other vascular system-based lesions, as
previously reported by Gunzer et al. (21), Pohlenz et al. (42)
found that piglets frequently developed renal tubular cell
apoptosis and necrosis. The sites of the renal tubular lesions
matched the sites where Stx2 binding and Gb3/CD77 expres-
sion were identified immunohistochemically (21). Gb3/CD77
and Stx2 binding were also demonstrated in cells of the glo-
meruli and arteriolar endothelium (21). Piglets inoculated with
other serotypes of E. coli that expressed variants of Stx2 (Stx2c,
Stx2d, Stx2d1, and Stx2d2) had renal lesions similar to those
caused by Stx2 E. coli O157:H7 (42).
In a previous study, we found that parenteral injection of
Stx1 into gnotobiotic piglets results in the same vascular and
ischemic lesions that are caused by Stx2 E. coli O157:H7.
Thus, the differences between the two toxins in infectious dis-
ease appear to be due to relative toxicity (14). The vascular
lesions in gnotobiotic pigs are essentially identical to those
reported in human cases (65), suggesting that this model is
relevant to the study of human E. coli O157:H7 disease (17).
Furthermore, in humans, as in the gnotobiotic pig model, Stx2
is more frequently associated with extraintestinal disease, in-
cluding HUS and CNS disease, than Stx1 is (40, 68). Purified
Stx2 is 1,000 times more toxic than Stx1 to human renal endo-
thelial cells (30) and causes severe renal damage in mice at a
lower dose than Stx1 (62). Administration of Stx2 to baboons
also causes HUS, while comparable concentrations of Stx1 do
not (53). Thus, substantial evidence has been presented that
Stx2 is a major contributor to sequellae associated with E. coli
O157:H7 infection.
Based on findings from previous studies, we hypothesized
that E. coli O157:H7 isolates from cattle feces are, on average,
less virulent than isolates from human patients with HUS. The
main objective of the present study was to test this hypothesis
using gnotobiotic piglets. A second objective was to determine
the extent to which expression levels of Stx1 and/or Stx2 cor-
relate with differences in virulence. A third objective was to
test the hypothesis that CNS lesions but not renal lesions are
correlated with the clinical demise of piglets.
MATERIALS AND METHODS
Bacterial strains. Ten E. coli O157:H7 strains originally isolated from human
disease outbreaks were obtained from Timothy J. Barrett of the Centers for
Diseases Control and Prevention in Atlanta, GA. Ten other E. coli O157:H7
strains originally isolated from healthy dairy cattle in the National Dairy Heifer
Survey conducted by the National Animal Health Monitoring System of the U.S.
Department of Agriculture were obtained from William Cray, Jr., of the National
Animal Disease Center in Ames, IA (Table 1) (4). Strain EDL933, which is
highly virulent in 1-day-old gnotobiotic piglets, was used as a positive control
(18). All strains were shown by PCR to possess the stx1, stx2, and eae genes.
Strains were stored in liquid nitrogen and cultured on blood agar plates (5%
sheep blood in heart infusion agar [Difco Laboratories, Detroit, MI]). For piglet
challenge, colony sweeps of bacteria were inoculated into 3 ml tryptic soy broth
(Difco) and incubated for 18 h at 37°C to obtain a concentration of approxi-
mately 1  109 CFU/ml. To assess the relative amount of Stx produced by each
strain in vitro, the bacterial concentration of each strain was normalized to an
optical density at 280 nm of 1.00.
Gnotobiotic challenge studies. Gnotobiotic piglets were derived by closed
hysterotomy and reared in sterile isolators using standard procedures (34). One
pig from each litter used in the study was inoculated with positive control strain
EDL933 to limit strain-by-litter bias and to ensure the susceptibility of pigs in the
litter to E. coli O157:H7. Litters containing control pigs that did not succumb to
EDL933 within 8 days of challenge were removed from the study. Each of the 20
E. coli O157:H7 strains tested for virulence was inoculated into five gnotobiotic
piglets. Litters of piglets were arbitrarily assigned to specific E. coli strains, and
typically the piglets were divided for testing with three or four strains. To further
reduce strain-by-litter bias, piglets from at least two different litters were used to
evaluate each strain, and piglets within litters were randomly assigned to indi-
vidual strains. All piglets were challenged per os with 3  109 CFU at 24 to 30 h
after birth, when it was demonstrated that the piglets were independently feed-
ing. Following challenge, piglets were observed for clinical signs of illness, in-
cluding diarrhea and CNS disease, at least three times daily for 8 days or until
they exhibited signs of CNS disease or were unable to eat. Signs ascribed to CNS
disease included head tilt, circling, lethargy, an inability to stand, lateral recum-
bency, and/or paddling (tonic-clonic convulsions). At 8 days postinoculation, or
when signs of CNS disease were exhibited, piglets were euthanized and subjected
to necropsy. At necropsy, pigs were examined for gross lesions, including intes-
tinal hemorrhage and mesocolonic edema. Specimens of the jejunum, ileum,
cecum, spiral colon, rectum, liver, lungs, heart, stomach, urinary bladder, kid-
neys, spleen, mesenteric lymph nodes, thymus, and spinal cord and the entire
brain were collected for histological analysis. Brains were sectioned at the level
of the medulla oblongata (olivary nucleus), cerebellum with medulla oblongata
(cerebellar peduncles), midbrain (corpora quadrigemina), and two levels of
cerebrum (interthalamic adhesion and genu of corpus callosum [18]). A section
of the colon was also collected for aerobic and anaerobic bacterial culture to
confirm the presence of the inoculated strain and to assess contamination.
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Histological examinations. Specimens collected for histologic analysis were
fixed in 10% neutral buffered formalin and processed for histopathology by
standard procedures, and tissues were stained with hematoxylin and eosin. Tissue
sections were subjected to routine microscopic examination for lesions; however,
in kidney tissue sections, the numbers of glomeruli and arterioles with lesions
compatible with Stx-induced damage (16, 37) were counted, and the resulting
data were included in the statistical analyses as separate counts. The pathologist
conducting microscopic examinations of the tissues (R.A.M.) was blinded to the
treatment groups of the piglets during the study.
Vero cell cytotoxicity assay. Bacterial strains were tested for Stx expression
using a Vero cell cytotoxicity assay (20). Bacteria were inoculated into 3 ml of
tryptic soy broth and incubated for 4 h at 37°C. Secreted toxins were extracted
with polymyxin B (25). Vero cells (CCL-91; American Type Culture Collection)
were plated with Dulbecco’s minimum Eagle’s medium (HyClone) containing
10% fetal bovine serum, penicillin (100 U/ml), and streptomycin (100 g/ml) in
96-well U-bottom microtiter plates to obtain a concentration of 2  104 cells/well
and incubated until the cells were confluent (18 h at 37°C in 5% CO2). The
concentration of toxin from each strain was determined in triplicate in each of
five separate trials. Extracts containing toxin from each E. coli O157:H7 strain
were added to Dulbecco’s minimum Eagle’s medium in the 96-well plates at an
initial dilution of 1:6 and diluted further in twofold increments. The Vero cells
in test wells were incubated with the diluted toxin extracts for 2 days. After
incubation, detached cells, medium, and toxin were removed by vigorous shak-
ing. The remaining cells were fixed with 2% formalin in 67 mM phosphate-
buffered saline (pH 7.4) for 1 min, after which the fixative was removed.
Attached cells were stained with 0.13% crystal violet in 5% ethanol–2% forma-
lin–phosphate-buffered saline for 20 min. Excess stain was removed by rinsing
the wells gently with distilled water. The plates were air dried, and the optical
density at 620 nm of the attached cells was determined spectrophotometrically.
The toxin titer (50% cytolethal dose) was calculated by determining the recip-
rocal of the dilution required to kill 50% of the Vero cells in a well of a 96-well
U-bottom microtiter plate.
Stx1 and Stx2 quantification. Relative concentrations of Stx1 or Stx2 produced
by E. coli O157:H7 strains during culture in tryptic soy broth at 37°C for 4 h were
determined after polymyxin B extraction by measurement with a verotoxigenic E.
coli reverse passive latex agglutination assay (Denka Seiken Co. Ltd., Tokyo,
Japan) (24).
Immunohistochemistry. Immunohistochemical detection of E. coli O157 an-
tigen in sections of urinary bladders from infected gnotobiotic piglets was con-
ducted by a modification of methods described previously (6). Rabbit anti-O157
antiserum (1:1,000 dilution; E. coli Reference Laboratory, Pennsylvania State
University) was used as the primary antiserum. Commercial goat anti-rabbit
immunoglobulin G and a streptavidin-alkaline phosphatase kit (DakoCytoma-
tion LSAB2 System-AP) were used for subsequent antigen detection steps.
Statistical analyses. The statistical significance of data (P  0.05) was analyzed
with Student’s t test, by analysis of variance (ANOVA) for mean days for the
“human” and “bovine” sources, and by analysis of covariance (ANCOVA) for
mean days for the “human” and “bovine” sources, as well as the Stx1/Stx2 ratio.
Logistic regression was used for data for “CNS,” “diarrhea,” “edema,” “attaching
and effacing (A/E) lesions,” and “infarcts” since these data were binomially
distributed. For both ANCOVA and logistic regression, the interaction between
the source (“human” and “bovine”) and the Stx1/Stx2 ratio was not statistically
significant.
RESULTS
E. coli EDL933 causes A/E lesions and CNS disease in gno-
tobiotic piglets. Eleven litters of piglets were utilized in this
study. A control piglet in one litter did not become clinically ill.
This litter was removed from the study to limit the effect of
piglet disease resistance on the assessment of strain virulence.
For the remaining 10 litters, the positive controls inoculated
with strain EDL933 exhibited signs of CNS disease or died 2 to
5 days postinoculation (mean  standard deviation, 3.7  0.9
days). Nine control piglets were euthanized, and one died
spontaneously. Eight of 10 control piglets exhibited diarrhea.
One of the two controls that did not develop diarrhea died 3
days postinoculation. The other control exhibited signs of CNS
disease on day 3 and was euthanized. The early demise of these
two control pigs may have precluded the development of di-
TABLE 1. Relationship between Stx2 toxin titers for E. coli O157:H7 strains (in vitro) and the symptoms and survival of
piglets infected with E. coli









Control EDL933 45 161 4.3 100 90 10
Human 3234-86 39 32 6.4 80 100 5
B8763 41 25 5.2 100 80 5
A7785 45 20 8.0 20 20 5
C9490 3 32 5.2 60 20 5
B1189 51 102 3.8 100 80 5
C509 48 102 3.4 100 100 5
C6183 T. J. Barrett 25 5.2 80 60 5
C8779 3 32 4.0 100 80 5
C7927 7 20 6.0 80 60 5
C4193 58 10 7.2 40 40 5
Bovine 2890 4 64 5.2 80 80 5
2893 4 2 8.0 0 20 5
2903 4 25 8.0 0 0 5
2909 4 16 6.6 40 20 5
3032 4 6 8.0 0 20 5
2922 4 2 8.0 0 0 5
2918 4 2 8.0 0 0 5
2939 4 40 5.2 100 100 5
2891 4 10 6.4 40 20 5
2977 4 51 5.4 80 80 5
a Relative concentration of Stx2 (in arbitrary units) as measured with a verotoxigenic E. coli reverse passive latex agglutination assay.
b Up to 8 days postinoculation.
7340 BAKER ET AL. APPL. ENVIRON. MICROBIOL.
arrhea in them. Nine of the 10 controls had microscopic evi-
dence of brain infarction. Histological sections from the intes-
tines of various control pigs exhibited attached bacteria with
lesions consistent with microvillus effacement. Mesocolonic
edema was observed at necropsy in euthanized control pigs.
The results for the 10 litters support the proposition that the
study measured differences in E. coli O157:H7 strain virulence
rather than variation in piglet susceptibility among litters. Nine
of 10 litters contained both piglets that developed CNS disease
and piglets that failed to develop CNS disease (as a conse-
quence of challenge with different E. coli strains). For only 1 of
20 strains (C9490) were the challenge outcomes different for
pigs from different litters.
On average, E. coli O157:H7 strains isolated from human
outbreaks are more virulent in gnotobiotic piglets than strains
isolated from healthy cattle. Piglets inoculated with E. coli
O157:H7 strains isolated from cattle and from patients in-
volved in disease outbreaks varied in their manifestations of
clinical signs and in the presence and extent of lesions (Table
1). Several strains were as virulent as or more virulent than
EDL933, while other strains were relatively attenuated. Based
on the development of CNS disease or death of inoculated
piglets, all of the human isolates were virulent, while only
one-half of the bovine strains were virulent. Despite great
variability within the groups, the human isolates were signifi-
cantly more likely to cause CNS disease and/or death (Table 2)
(76% versus 34%; P  0.023, logistic regression). In addition,
the numbers of days that piglets survived after challenge were
significantly less for pigs that received outbreak strains than for
pigs that received bovine isolates (5.4 days versus 6.9 days; P 
0.032, ANOVA). Pigs inoculated with human disease strains
showed a greater, but not a statistically significant greater,
incidence of brain infarcts (64% versus 34%; P  0.07, logistic
regression). There was no significant difference between treat-
ment groups in terms of mesocolonic edema, diarrhea, or A/E
lesions.
CNS disease symptoms are correlated with postmortem ob-
servation of brain necrosis (infarcts). We previously observed
that piglets typically die within several hours of manifestation
of clinical signs consistent with disease of the CNS (18). To
minimize piglet suffering and to preclude postmortem autolysis
of tissues, piglets were euthanized immediately after CNS dis-
ease symptoms were observed. Appropriate recognition of
signs of CNS disease was established by the high correlation
between signs of CNS disease and the postmortem observation
of infarcts in sections of brain tissue (R2  88.4% and P 
0.001, ANOVA). Brain necrosis was not correlated with the
presence of mesocolonic edema, diarrhea, or A/E lesions, nor
was diarrhea correlated with the presence of mesocolonic
edema or A/E lesions.
Stx2 production is correlated with the virulence of E. coli
O157:H7 strains. The amount of Stx2 produced by E. coli
O157:H7 strains was correlated with a reduction in survival to
the end of the study (P  0.001, ANCOVA) (Table 3 and Fig.
1). Stx2 production was also correlated with manifestation of
signs of CNS disease (P  0.003) (Table 3) and brain necrosis
(infarcts) (P  0.003) (Table 3), but not with mesocolonic
edema, diarrhea, or A/E lesions. The correlation coefficients
and significance were similar whether Stx2 data obtained from
Vero cell cytotoxicity assays or enzyme-linked immunosorbent
assays were used. The amount of Stx1 produced in culture was
not correlated with the length of time that a piglet survived,
with manifestation of CNS disease or brain infarcts, or with the
FIG. 1. Relationship between Stx2 titer and number of days of
survival postinfection.
TABLE 2. Disease indicators for piglets infected with bovine or
human strains of E. coli O157:H7a
Symptom





Death or CNS disease 17b 38
Brain infarcts 17 32
Diarrhea 45 49
A/E lesions 34 38
Mesocolonic edema 41 47
a Five piglets were infected with 10 strains of bovine origin and 10 strains of
human origin. The potential postchallenge survival time, 8.0 days (termination of
the study), was reduced to 6.9 and 5.4 days by bovine and human isolates,
respectively (P  0.03, ANOVA).
b Significantly different (P  0.05, ANOVA).
TABLE 3. Correlation between outcome variables and Stx1 and
Stx2 productiona
Stx Outcome variable P value












a ANCOVA (mean number of days of survival) and logistic regression (all
other variables) were used for assessment.
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presence of mesocolonic edema, diarrhea, or A/E lesions (Ta-
ble 3).
Kidney lesions. Lesions consistent with the lesions previ-
ously described (21, 42) were observed in the kidneys of most
pigs in the study, including those challenged with positive con-
trol strain EDL933. Of 109 piglets whose renal tissue was
examined histologically, 85% had lesions in the glomeruli, 59%
had lesions involving arterioles, 52% had lesions in both glo-
meruli and arterioles, 61% had lesions involving tubules, 91%
had lesions in either or both glomeruli and arterioles, and 95%
had lesions involving one or more of the three areas. The
lesions in the glomeruli included capillary endothelial swelling,
capillary congestion, fibrin-platelet thrombi, thickening and
fibroplasia of Bowman’s capsule, and proliferation of mesan-
gial cells. Each individual glomerulus that was counted as pos-
itive exhibited two or more of these lesions. Arterioles with
lesions exhibited TMA with endothelial swelling and prolifer-
ation, concentric intimal thickening, fibrinoid change of the
tunica intima and media, and fibrin thrombi. The tubular le-
sions included necrosis and/or apoptosis, dilatation, and lumi-
nal accumulation of sloughed epithelial cells or neutrophils.
The number of tubular lesions per tissue section was not quan-
tified since some of the changes (e.g., dilatation) were too
numerous to count and not necessarily specific for toxin-in-
duced damage. Statistical analysis did not establish a significant
correlation between kidney glomerular or arteriolar lesions
and CNS disease (P  0.57 and P  0.098, respectively, Stu-
dent’s t test). Nor was a significant correlation observed be-
tween kidney lesions and Stx2 production by challenge strains
(for Stx2 versus glomerular lesions, R2  0.2% and P  0.28,
as determined by regression analysis; for Stx2 versus arteriolar
lesions, R2  0.2% and P  0.28, as determined by regression
analysis).
Atypical lesions. Lesions that were either uncommon or not
previously described in this model were observed in some an-
imals, but they did not appear to be due to a unique virulence
attribute of any particular strain. Purulent cystitis that was mild
to moderate and subacute to chronic was seen in 14 of 105
(13.3%) piglets whose urinary bladder was microscopically ex-
amined. Lesions in the urinary bladder were characterized by
infiltration of the mucosal epithelium with neutrophils, by in-
filtration of the propria submucosa with lymphocytes, by
smaller numbers of macrophages, and by granulation tissue
formation. In 8 of 14 piglets with cystitis (57.1%), inflammatory
lesions were associated with coccobacillary bacterial attach-
ment to the surfaces of mucosal transitional epithelial cells.
Immunohistochemical analysis to detect the O157 antigen (6)
was conducted using urinary bladder sections from all piglets in
which bacterial colonization was observed. Adherent bacteria,
when present, stained positive for the O157 antigen in all cases,
confirming that E. coli O157:H7 had infected the urinary blad-
der. In addition to the aforementioned renal lesions, two pig-
lets had mild interstitial nephritis and two piglets had mild
pyelitis (inflammation of the pelvic epithelium of the kidney);
both of the latter piglets also had cystitis. Eight of 126 piglets
(6.3%) developed bronchopneumonia, and there were signifi-
cant lesions in two animals. Lung lesions appeared to have
been caused by aspiration of small amounts of milk containing
bacterial inoculum. Five piglets had mild erosive gastritis.
In addition to A/E lesions, other clinically significant lesions
were seen in the lower small and large intestines of some
piglets. Necrosuppurative inflammation of the ileum, cecum,
and colon was seen in five piglets (4.0%), and lesions were
ulcerative in two of these animals. Three piglets (2.4%) had
lesions suggestive of ischemic bowel necrosis. In one of these
animals, lesions were associated with widespread thrombosis of
small blood vessels in multiple organs, including the ileum,
cecum, and colon. In the second piglet, coagulative necrosis of
villi in the ileum was seen without widespread thrombosis in
other organs. In the third piglet, lesions were extensive, with
full-thickness necrosis of the ileal mucosa (Fig. 2) and necro-
hemorrhagic colitis (Fig. 3). Mucosal necrosis in the colon
spared the deep portions of the crypts and was characterized by
loss of the superficial portions and replacement by suffusive
hemorrhage that filled the lamina propria.
DISCUSSION
We showed that E. coli O157:H7 strains isolated from
healthy cattle are, on average, less virulent in gnotobiotic pig-
lets than E. coli O157:H7 strains isolated from human disease
outbreaks. Virulence was highly correlated with in vitro pro-
duction of Stx2 but not Stx1. We suggest that disease outbreaks
may select for producers of high levels of Stx2 among E. coli
O157:H7 strains shed by animals. This hypothesis is consistent
with the findings of Ritchie et al., who reported that both the
basal and mitomycin-enhanced Stx2 production by isolates
from patients with HUS was greater than that by isolates from
cattle (46). Gally et al. showed that strains isolated from spo-
radic or outbreak cases of disease had enhanced expression of
EspD and Tir compared to bovine isolates, despite essentially
identical strain genotypes (Stx production was not tested) (32,
33, 49, 50). Together, these observations suggest that there
may be a general regulatory difference in virulence genes be-
tween strains with high virulence and strains with low virulence
and that there is selection for greater virulence factor expres-
sion in more virulent strains.
A potential mechanism governing Stx2 expression differ-
ences is suggested by the observations of Muniesa et al. re-
garding Stx2 variability among outbreak strains (36). Isolated
strains were grouped based on the amount of phage released
after mitomycin C induction. Strains that released fewer phage
were found to harbor two phage types, LC159 and SC370,
although only SC370 was detected in supernatants of induced
cultures. When SC370 was absent, large amounts of LC159
were released, and the higher level of phage production was
accompanied by an increased amount of Stx2 in the cultures.
Some relationship was detected between phage production and
the severity of the disease observed in patients from which the
E. coli O157:H7 strains were isolated (36). These observations
suggest that interaction between different phages may affect
toxin regulation. Kim et al. revealed the existence of two dis-
tinctly different lineages of E. coli O157:H7 through octamer-
based genome scanning (27). Human and bovine isolates were
not randomly distributed between lineages. Restriction frag-
ment length polymorphism analysis with lambdoid phage ge-
nomes indicated that phage-associated polymorphisms segre-
gate precisely along lineages predicted by octamer-based
genome scanning. Thus, highly virulent strains (which also
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FIG. 2. Urinary bladder of a gnotobiotic piglet (animal 15627) infected with E. coli O157:H7. (A) Neutrophils have multifocally infiltrated the
mucosa. The mucosa and propria submucosa are hemorrhagic. Foci of bacterial colonization (arrows) are present on the mucosal surface, with
bacteria attached to transitional epithelial cells. (B) Additional sections were cut from the same block of paraffin-embedded tissue and stained
immunohistochemically for E. coli O157 antigen. The bacteria attached to transitional epithelial cells and colonizing the mucosa were identified
as E. coli O157; the red reaction product indicated a positive result (arrows). Tissue sections were counterstained with hematoxylin.
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produce high levels of Stx2) may represent a particular lineage
of E. coli O157:H7 strains.
A few pigs developed lesions not previously described for
gnotobiotic piglets infected with E. coli O157:H7. Most notable
of these were cystitis and hemorrhagic colitis lesions. Infection
by E. coli O157:H7 or other Stx-producing E. coli strains of the
urinary tract has not been reported in animal models but can
be a prodrome to HUS in humans (11, 23, 52, 56, 59). Hem-
orrhagic colitis is a common feature in clinically recognized
human infections, but this condition has not been previously
reported to be an outcome of experimental infectious chal-
lenge in nonprimate animal models. The several instances of
FIG. 3. Intestines of a gnotobiotic piglet (animal 12573) infected with E. coli O157:H7. (A) Ileum. There is coagulative necrosis involving the
full thickness of the mucosa and remnants of surviving epithelium at the bases of some crypts in the process of regeneration. Hyperemia and
hemorrhage are evident at the junction of the mucosa with the submucosa, but hemolysis obscures evidence of hemorrhage superficial to this
region. Blood vessels in the mucosa are hyperemic, and some of them (not seen at this magnification) are necrotic and thrombosed. There is edema
of the submucosa with associated lymphatic blood vessel dilatation. (B) The superficial mucosa has undergone necrosis and replacement with
suffusive hemorrhage that fills the lamina propria. Necrosis has spared the deeper portions of the crypts in the mucosa. Blood vessels in the mucosa
are hyperemic, and some of them (not seen at this magnification) are necrotic and thrombosed. The submucosa is edematous. Tissue sections were
stained with hematoxylin and eosin.
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necrotic and/or hemorrhagic lesions in the intestines of pigs in
this study indicate that these animals are subject to these le-
sions, although they may be uncommon. Necrohemorrhagic
intestinal lesions in the gnotobiotic piglet model were presum-
ably secondary to ischemic necrosis and were essentially iden-
tical to the lesions which we saw previously in gnotobiotic
piglets inoculated with Stx1 (14). They also closely resembled
lesions seen in human patients with E. coli O157:H7 infections
(22, 28, 35).
Recently, previously unrecognized lesions in the kidneys of
gnotobiotic piglets infected with E. coli O157:H7 were re-
ported (21, 42). Collectively in the two studies, renal lesions
involved changes in the glomeruli, the afferent arterioles and
small arteries, and the tubules. Glomeruli were affected with
endothelial swelling, narrowing of the capillary lumina, con-
gestion, and thrombosis. TMA preferentially affected afferent
arterioles and, to a lesser extent, small arteries, whereas larger
arteries were unaffected. Tubular epithelial apoptosis, degen-
eration, and necrosis were also seen (42). The locations of the
vascular and tubular lesions matched the locations where Stx2
binding and the Stx2 receptor (Gb3) were identified immuno-
histochemically (42). In the present study, based on histologi-
cal examination, 95% of the piglets had lesions consistent with
those previously described which involved one or more of the
three target sites (i.e., arterioles, glomeruli, and tubules). How-
ever, the presence of the lesions correlated with neither pa-
rameters of life-threatening clinical illness nor the relative
amount of Stx2 produced by the challenge strains. Since pre-
vious studies have provided strong evidence that renal lesions
in piglets are due to Stx2 and that these lesions resemble
lesions seen in human patients with HUS, has been proposed
that the gnotobiotic piglet is a relevant model for HUS (21,
42). However, a consistent finding in different studies, includ-
ing the present study, is that the piglets die from brain damage
and not from the clinical features of HUS (i.e., hemolytic
anemia, thrombocytopenia, and renal failure). In the present
study the hypothesis was that CNS lesions and not renal lesions
are correlated with the clinical demise of the piglets; this was
found to be the case. It may be that a piglet has greater
susceptibility to Stx2-mediated damage in the brain and that
the life-threatening nature of the lesions that result cause
death before renal lesions have a chance to progress to clinical
HUS. Alternatively, another possible explanation is that other
putative factors necessary for the development of clinical HUS
(60) are not present in the neonatal gnotobiotic piglet model.
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